ARTICLES BY ALEXANDER K. AUST
-
Draft FDA Labeling Guidance Proposes More Clarity For Providers3/7/2023
The FDA's draft guidance for prescription and biologic drugs updates a 2010 guidance and comes following the boom of activity in the biologics space. This article breaks down and analyzes the update on labeling for prescription drugs and biologics on an increasingly complex landscape.
This website uses cookies to ensure you get the best experience on our website. Learn more